Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis
- Hungria, V.
- Martínez-Baños, D.M.
- Mateos, M.-V.
- Dimopoulos, M.A.
- Cavo, M.
- Heeg, B.
- Garcia, A.
- Lam, A.
- Machnicki, G.
- He, J.
- Fernandez, M.
ISSN: 1865-8652, 0741-238X
Year of publication: 2020
Volume: 37
Issue: 12
Pages: 4996-5009
Type: Article